Agilent Technologies A
NYSE A
$156.34 +2.65 (+1.72%)
As of: Sep 17, 2026 · 3:59 PM EDT

Agilent Technologies (A) EBT Margin Growth (3y) (2013 - 2026)

Analysis

Agilent Technologies (A) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 266.00
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -211.00
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 1,575.00
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 3,000.00
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -138.00
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -730.00
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 30,357.00
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -871.00
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 2,904.00
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -1,462.00
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 1,575.00
Apr 30, 2026 28.00
Jan 31, 2026 -310.00
Oct 31, 2025 -86.00
Jul 31, 2025 -205.00
Apr 30, 2025 -513.00
Jan 31, 2025 278.00
Oct 31, 2024 -341.00
Jul 31, 2024 112.00
Apr 30, 2024 587.00
Jan 31, 2024 415.00
Oct 31, 2023 580.00
Jul 31, 2023 -947.00
Apr 30, 2023 1,218.00
Jan 31, 2023 721.00
Oct 31, 2022 771.00
Jul 31, 2022 568.00
Apr 30, 2022 311.00
Jan 31, 2022 -26.00
Oct 31, 2021 813.00